NONLINEAR BINDING OF VALPROIC ACID (VPA) AND E-DELTA-2-VALPROIC ACID TO RAT PLASMA-PROTEINS

被引:27
作者
SEMMES, RLO [1 ]
SHEN, DD [1 ]
机构
[1] UNIV WASHINGTON,SCH PHARM,DEPT PHARMACEUT,BG-20,SEATTLE,WA 98195
关键词
branched-chain fatty acids; E-Δ[!sup]2[!/sup]-valproic acid; protein binding; rat plasma proteins; valproic acid;
D O I
10.1023/A:1015804413818
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The binding characteristics of valproic acid (VPA) and its pharmacologically active monounsaturated metabolite, E-Δ2-VPA, to rat plasma proteins were compared. The plasma free fraction was determined by a rapid equilibrium procedure, which minimizes the interfering effects of nonesterified fatty acids liberated by in vitro lipolysis. Nonlinear binding behavior was observed with both compounds over their respective pharmacologic concentration range. Multiple binding-site models were invoked to explain the binding isotherm. The 2-unsaturated compound has a much higher affinity for the rat plasma proteins (mainly albumin) than its saturated precursor. The equilibrium association constants for the high- and intermediate-affinity sites were more than an order of magnitude higher with E-Δ2-VPA than with VPA (104–106 versus 103M−1). This difference in binding affinity was also reflected by a lower plasma free fraction for E-Δ2-VPA compared with VPA (<<10 versus >20% at total concentrations of less than 100 µg/ml). A more pronounced dose- and concentration-dependent variation in the distribution and clearance kinetics is predicted for the 2-unsaturated analogue compared to VPA. Also, the structural dependency in plasma protein binding observed with these branched-chain fatty acids may provide insights into the mechanism of interaction between fatty acyl molecules and albumin. © 1990, Plenum Publishing Corporation. All rights reserved.
引用
收藏
页码:461 / 467
页数:7
相关论文
共 39 条
[31]   DETERMINATION OF UN-BOUND VALPROIC ACID CONCENTRATION IN PLASMA BY EQUILIBRIUM DIALYSIS AND GAS-LIQUID-CHROMATOGRAPHY - METHODOLOGICAL ASPECTS AND OBSERVATIONS IN EPILEPTIC PATIENTS [J].
RIVA, R ;
ALBANI, F ;
BARUZZI, A ;
GALVANI, I ;
PERUCCA, E .
THERAPEUTIC DRUG MONITORING, 1982, 4 (04) :341-352
[33]  
ROSNER B, 1982, FUNDAMENTALS BIOSTAT, P232
[34]  
SCHAFER H, 1984, METABOLISM ANTIEPILE, P73
[35]   CAPILLARY GAS-CHROMATOGRAPHIC ASSAY FOR VALPROIC ACID AND ITS 2-DESATURATED METABOLITE IN BRAIN AND PLASMA [J].
SEMMES, RLO ;
SHEN, DD .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 432 :185-197
[36]   VALPROATE COMPETES WITH PALMITATE FOR BINDING TO SERUM-ALBUMIN [J].
VORUM, H ;
ANDERSEN, S ;
BRODERSEN, R .
EPILEPSIA, 1989, 30 (03) :370-373
[37]   APPLICATION OF AKAIKES INFORMATION CRITERION (AIC) IN EVALUATION OF LINEAR PHARMACOKINETIC EQUATIONS [J].
YAMAOKA, K ;
NAKAGAWA, T ;
UNO, T .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (02) :165-175
[38]   DOSE-DEPENDENT PHARMACOKINETICS OF VALPROATE IN GUINEA-PIGS OF DIFFERENT AGES [J].
YU, HY ;
SHEN, YZ ;
SUGIYAMA, Y ;
HANANO, M .
EPILEPSIA, 1987, 28 (06) :680-687
[39]   PROTEIN-BINDING OF VALPROIC ACID IN THE PRESENCE OF ELEVATED FREE FATTY-ACIDS IN PATIENT AND NORMAL HUMAN-SERUM [J].
ZIMMERMAN, CL ;
PATEL, IH ;
LEVY, RH ;
EDWARDS, D ;
NELSON, SD ;
HUTCHINSON, M .
EPILEPSIA, 1981, 22 (01) :11-17